Grade 2 cellular heart rejection: does it exist?: Yes!
Kemnitz
J
J
D004699:Endocardium / Q000473:pathology*; D006084:Graft Rejection / Q000145:classification / Q000276:immunology / Q000473:pathology*; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use; D009206:Myocardium / Q000473:pathology*; D011379:Prognosis
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3